The influence of new antithrombotic drugs on regional anesthesia

Current Opinion in Anaesthesiology

Volumn 19, Issue 5, 2006, Pages 545-550

  Gogarten, Wiebke ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Guidelines; Introduction and risk evaluation; Neuraxial blockade; Peripheral nerve blocks; Spinal epidural hematoma; Thromboembolism prophylaxis

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; ENOXAPARIN; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; FONDAPARINUX; HEPARIN; HIRUDIN; LOCAL ANESTHETIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; TICLOPIDINE; TIROFIBAN; WARFARIN;

AGING; ANESTHESIA COMPLICATION; ANKYLOSING SPONDYLITIS; APLASTIC ANEMIA; BLEEDING; BLOOD CLOTTING DISORDER; CASE STUDY; CATHETERIZATION; DRUG WITHDRAWAL; FEMALE; HEART SURGERY; HERBAL MEDICINE; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; LOW DRUG DOSE; NERVE BLOCK; OBSTETRIC PATIENT; PARAPLEGIA; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; REGIONAL ANESTHESIA; REVIEW; RISK FACTOR; SPINAL HEMATOMA; SURGICAL PATIENT; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; THROMBOEMBOLISM;

ADENOSINE DIPHOSPHATE; ANESTHESIA, CONDUCTION; ANESTHESIA, EPIDURAL; ASPIRIN; CARDIAC SURGICAL PROCEDURES; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; DRUG ADMINISTRATION SCHEDULE; FEMALE; FIBRINOLYTIC AGENTS; HEMATOMA, EPIDURAL, SPINAL; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; NERVE BLOCK; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PLANT PREPARATIONS; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POLYSACCHARIDES; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RISK ASSESSMENT; RISK FACTORS;

EID: 33748663560     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aco.0000245282.45529.b0     Document Type: Review

References (49)

1. Vandermeulen EP, Van Aken H, Vermylen J. Anticoagulants and spinalepidural anesthesia. Anesth Analg 1994; 79:1165-1177.
2. Schroeder DR. Statistics: detecting a rare adverse drug reaction using spontaneous reports. Reg Anesth Pain Med 1998; 23 (Suppl 2):183-189.
3. Moen V, Dahlgren N, Irestedt L. Severe neurological complications after central neuraxial blockades in Sweden 1990-1999. Anesthesiology 2004; 101:950-959.
4. Gogarten W, Van Aken H, Büttner J, et al. Neuraxial blockade and thromboembolism prophylaxis/antithrombotic therapy: revised recommendations of the German Society of Anaesthesiology and Intensive Care. Anaesth Intensivmed 2003; 44:218-230.
5. Horlocker TT, Wedel DJ, Benzon H, et al. Regional anesthesia in the anticoagulated patient: defining the risks (The second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med 2003; 28:172-197.
6. Guideline on neuraxial blockade and antithrombotic therapy; 2003. http://www.anesthesiologie.nl/richtlijnen. [Accessed 28 July 2006]
7. Vandermeulen EP, Singelyn F, Vercauteren M, et al. Belgian guidelines concerning central neural blockade in patients with drug-induced alteration of coagulation: an update. Acta Anaesthesiol Belg 2005; 56:139-146.
8. Kozek-Langenecker SA, Fries D, Gütl M, et al. Locoregional anesthesia and coagulation inhibitors: recommendations of the Task Force on Perioperative Coagulation of the Austrian Society for Anesthesiology and Intensive Care Medicine. Anaesthesist 2005; 54:476-484.
9. Strebel N, Prins M, Agnelli G, Büller HR. Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery. Arch Intern Med 2002; 162:1451-1456.
10. Sanderink GJ, Guimart CG, Ozoux ML, et al. Pharmacokinetics and pharmacodynamics of the prophylactic dose of enoxaparin once daily over 4 days in patients with renal impairment. Thromb Res 2002; 105:225-231.
11. Turpie AGG, Bauer KA, Eriksson BI, Lassen MR, Studies ftSCotPOP. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med 2002; 162:1833-1840.
12. Agnelli G, Bergquist D, Cohen AT, et al. Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. Br J Surg 2005; 92:1212-1220.
13. Turpie AGG, Gallus AS, Hoek JA. A synthetic pentasaccharide for the prevention of deep-vein thrombosis [letter]. N Engl J Med 2001; 345:292-293.
14. Patrono C, Coller B, FitzGerald GA, et al. Platelet-active drugs: the relationships among dose, effectiveness, and side effects. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126:234S-264S.
15. CLASP. A randomized trial of low dose aspirin for the prevention and treatment of preeclampsia among 9364 pregnant women. Lancet 1994; 343:619-629.
16. Horlocker TT, Wedel DJ, Schroeder DR, et al. Preoperative antiplatelet therapy does not increase the risk of spinal hematoma associated with regional anesthesia. Anesth Analg 1995; 80:303-309.
17. Horlocker TT, Bajwa ZH, Ashraf Z, et al. Risk assessment of hemorrhagic complications associated with nonsteroidal antiinflammatory medications in ambulatory pain clinic patients undergoing epidural steroid injection. Anesth Analg 2002; 95:1691-1697.
18. Gibbs NM, Weightman WM, Thrackray NM, et al. The effects of recent aspirin ingestion on platelet function in cardiac surgical patients. Eur J Anaesthesiol 2001; 15:55-59.
19. Walker AM, Jick H. Predictors of bleeding during heparin therapy. JAMA 1980; 244:1209-1212.
20. Ferraris VA, Ferraris SP, Joseph O, et al. Aspirin and postoperative bleeding after coronary artery bypass grafting. Ann Surg 2002; 235:820-827.
21. Burger W, Chemnitius JM, Kneissl GD, Rücker G. Low-dose aspirin for secondary cardiovascular prevention: cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation: review and metaanalysis. J Intern Med 2005; 257:399-414. This metaanalysis highlights the perioperative risks with aspirin withdrawal as well as bleeding risks with continuation of aspirin therapy.
22. Ruff RR, Dougherty JH. Complications of lumbar puncture followed by anticoagulation. Stroke 1981; 12:879-881.
23. Stafford-Smith M. Impaired haemostasis and regional anaesthesia. Can J Anaesth 1996; 43:R129-R135.
24. Savi P, Herbert JM. Clopidogrel ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis. Semin Thromb Hemost 2005; 31:174-183.
25. Silber S, Albertsson P, Aviles FF, et al. The task force for percutaneous coronary interventions of the European Society of Cardiology. Eur Heart J 2005; 26:804-847.
26. Englberger L, Faeh B, Berdat PA, et al. Impact of clopidogrel in coronary artery bypass grafting. Eur J Card Thorac Surg 2004; 26:96-101.
27. Kapetanakis EI, Medlam DA, Petro KR, et al. Effect of clopidogrel premedication in off-pump cardiac surgery. Circulation 2006; 113:1667-1674. This study substantiates the bleeding risks involved in continued clopidogrel medication.
28. Vandermeulen E. Is anticoagulation and central neural blockade a safe combination? Curr Opin Anaesthesiol 1999; 12:539-543.
29. Wilson SH, Fasseas P, Orford JL, et al. Clinical outcome of patients undergoing noncardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 2003; 42:234-240.
30. Denninger MH, Necciari J, Serre-Lacroix E, Sissmann J. Clopidogrel antiplatelet activity is independent of age and presence of atherosclerosis. Semin Thromb Hemost 1999; 25 (Suppl 2):41-45.
31. Gammie JS, Zenati M, Kormos RL, et al. Abciximab and excessive bleeding in patients undergoing emergency cardiac operations. Ann Thorac Surg 1998; 65:465-469.
32. Antithrombotic, Trialists and Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324:71-86.
33. Lim MJ, Eagle KA, Gore JM, et al. Treating patients with acute coronary syndromes with aggressive antiplatelet therapy (from the Global Registry of Acute Coronary Events). Am J Cardiol 2005; 96:917-921.
34. Bizzarri F, Scolletta S, Tucci E, et al. Perioperative use of tirofiban hydrochoride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting. J Thorac Cardiovasc Surg 2001; 122:1181-1185.
35. Apitz-Castro R, Badimon JJ, Badimon L. Effect of ajoene, the major antiplatelet compound from garlic, on platelet thrombus formation. Thromb Res 1992; 68:145-155.
36. Bebbington A, Kulkarni R, Roberts P. Ginkgo Biloba: persistent bleeding after total hip arthroplasty caused by herbal self-medication. J Arthroplasty 2005; 20:125-126.
37. Rose KD, Croissant PD, Parliament CF, Levin MP. Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: a case report. Neurosurgery 1990; 26:880-882.
38. Kam PCA, Liew S. Traditional Chinese herbal medicine and anaesthesia. Anaesthesia 2002; 57:1083-1089.
39. Kwok Y, Ng KFJ, Li CCF, et al. A prospective, randomized, double-blind, placebo-controlled study of the platelet and global hemostatid effects of Ganoderma Lucidum (Ling-Zhi) in healthy volunteers. Anesth Analg 2005; 101:423-426.
40. Farah MH, Edwards R, Lindquist M, et al. International monitoring of adverse health effects associated with herbal medicines. Pharmacoepidemiol Drug Safety 2000; 9:105-112.
41. Ernst E. Serious adverse effects of unconventional therapies for children and adolescents: a systematic review of recent evidence. Eur J Pediatr 2003; 162:72-80.
42. Liu SS, Block BM, Wu CL. Effects of perioperative central neuraxial analgesia on outcome after coronary artery bypass surgery. Anesthesiology 2004; 101:153-161.
43. Roediger L, Larbuisson R, Lamy M. New approaches and old controversies to postoperative pain control following cardiac surgery. Eur J Anaesthesiol 2006; 23:539-550.
44. Chaney MA. Cardiac surgery and intrathecal/epidural techniques: at the crossroads? Can J Anaesth 2005; 52:783-788. This invaluable editorial on the risks and benefits of neuraxial blockade should be read by anyone performing neuraxial blockade in cardiac surgery.
45. Ho AM, Chung DC, Joynt GM. Neuraxial blockade and hematoma in cardiac surgery: estimating the risk of a rare adverse event that has not (yet) occurred. Chest 2000; 117:551-555.
46. Weller RS, Gerancher JC, Crews JC, Wade KL. Extensive retroperitoneal hematoma without neurologic deficit in two patients who underwent lumbar plexus block and were later anticoagulated. Anesthesiology 2003; 98:581-585.
47. Aveline C, Bonnet F. Delayed retroperitoneal haematoma after failed lumbar plexus block. Br J Anaesth 2004; 93:589-591.
48. Maier C, Gleim M, Weiss T, et al. Severe bleeding following lumbar sympathetic blockade in two patients under medication with irreversible platelet aggregation inhibitors. Anesthesiology 2002; 97:740-743.
49. Büttner J, Bürkle H, Gogarten W, Wulf H. Thromboembolism prophylaxis and peripheral nerve blocks: guideline of the German Society of Anaesthesiology and Intensive Care. Anaesth Intensivmed 2005; 46:319-322.